Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Blood cancers, Chronic leukaemia, Chronic lymphocytic leukaemia (CLL), Leukaemia
Closed
Other
This trial is looking at how idelalisib works for people with chronic lymphocytic leukaemia (CLL). It is for people whose CLL came back or got worse whilst taking ibrutinib. Or they are not able to have ibrutinib and they have been treated for their CLL before but it has come back or got worse.
Recruitment start: 13 July 2015
Recruitment end: 20 March 2018
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Peter Hillmen
Bloodwise
Experimental Cancer Medicine Centre (ECMC)
Gilead
NIHR Clinical Research Network: Cancer
University of Birmingham
Last reviewed: 9 April 2018
CRUK internal database number: 9673
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
